ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.

Takahito Sugase; Takashi Kanemura; Norihiro Matsuura; Kei Yamamoto; Yuki Ushimaru; Yasunori Masuike; Yoshitomo Yanagimoto; Kazuyoshi Yamamoto; Yoshihiro Sakano; Ryota Mori; Masatoshi Kitakaze; Masahiko Kubo; Yasunari Fukuda; Hisateru Komatsu; Masaaki Miyo; Toshinori Sueda; Yoshinori Kagawa; Kunihito Gotoh; Shogo Kobayashi; Hiroshi Miyata

doi:10.1245/s10434-026-19709-8

← 뒤로

ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.

1/5 보강

Annals of surgical oncology 📖 저널 OA 22.4% 2021~2026 2026 Esophageal Cancer Research and Treat

OpenAlex 토픽 · Esophageal Cancer Research and Treatment Cancer Immunotherapy and Biomarkers Cancer, Stress, Anesthesia, and Immune Response

Sugase T, Kanemura T, Matsuura N, Yamamoto K, Ushimaru Y, Masuike Y

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Takahito Sugase, Takashi Kanemura, et al. (2026). ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-19709-8

MLA Takahito Sugase, et al.. "ASO Visual Abstract: Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.." Annals of surgical oncology, 2026.

PMID 42020916 ↗

DOI 10.1245/s10434-026-19709-8

같은 제1저자의 인용 많은 논문 (1)

Risk Stratification of Postoperative Recurrence After Adjuvant Nivolumab for Resected Locally Advanced Esophageal Cancer: A Real-World Study.
Annals of surgical oncology 2026